Walleye Trading LLC Spring Works Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $73,000 - $105,000	2,000 New	2,000 $98,000
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $32,368 - $43,932	1,400 New	1,400 $32,000
Q2 2022 Aug 08, 2022	SELL	$18.36 - $60.07 $29,376 - $96,112	-1,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $78,352 - $104,735	1,600 New	1,600 $90,000

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.